Home Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients
Article
Licensed
Unlicensed Requires Authentication

Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients

  • Chandrika Nayak , Dinesh Nayak , Surekha Bhat , Annaswamy Raja and Anjali Rao
Published/Copyright: May 7, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 5

Abstract

Background: Experimental data indicate that destructive oxidative events reach their peak within the first 24 h after trauma in head injury (HI) and that brain damage occurring due to this impact can be the cause of death or irreversible permanent disabilities in affected patients.

Methods: Venous blood samples were obtained from 50 HI patients within 24 h of trauma onset and from 30 age- and sex-matched normal controls (NC). Patients were divided into three different neurological outcome groups: those who died within 10 days of trauma (D), and those with severe neurological deficits (SD) or mild/no neurological deficits (MD) at 90 days after trauma. Early oxidative changes in erythrocytes were assessed by estimating an indicator of lipid peroxidative damage – thiobarbituric acid-reactive substances (TBARS) – and antioxidants [reduced glutathione (GSH) levels and superoxide dismutase (SOD) activity].

Results: In the D group, erythrocyte TBARS levels were significantly higher compared to the NC, SD and MD groups (p<0.001); GSH levels were significantly lower compared to the NC (p<0.001) and MD (p<0.01) groups and SOD activity was significantly higher than in the NC (p<0.01) and MD (p<0.01) groups. In the SD group, TBARS levels were significantly higher than in the NC (p<0.001) and MD (p<0.05) groups; GSH levels were significantly lower than in the NC (p<0.001) and MD (p<0.01) groups and SOD activity was higher compared to the NC and MD (p<0.01) groups. In the MD group, TBARS levels were significantly higher and GSH levels significantly lower compared to the NC group (p<0.001). However, we did not observe any significant change in SOD activity compared to the NC group.

Conclusions: These findings indicate that early oxidative changes may reflect the severity of neurological insult and provide an early indication of patient outcome in traumatic HI.

Clin Chem Lab Med 2007;45:629–33.


Corresponding author: Dr. Chandrika Nayak, Assistant Prof. of Biochemistry, Melaka Manipal Medical College (Manipal Campus), International Center for Health Sciences, Manipal 576 104, Karnataka, India Phone: +91-820-2922570, Fax: +91-820-2571905,

Received: 2006-11-20
Accepted: 2007-2-11
Published Online: 2007-05-07
Published in Print: 2007-05-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. 6th Conference on Homocysteine Metabolism, World Congress on Hyperhomocysteinemia, Saarbruecken/Germany June 5-9, 2007
  2. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes
  3. Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
  4. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
  5. Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels
  6. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions
  7. HLA-DQA1 and -DQB1 allele typing in southern Taiwanese women with breast cancer
  8. Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol
  9. Frequency of two human glutathione-S-transferase omega-1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method
  10. Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case
  11. Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients
  12. Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
  13. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome
  14. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry
  15. Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats
  16. Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
  17. Measurement of calcitonin by immunoassay analyzers
  18. Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X
  19. Quality indicators and specifications for key processes in clinical laboratories: a preliminary experience
  20. Analytical and clinical performance of three natriuretic peptide tests in the emergency room
  21. Quality of serum creatinine measurement in light of EQA programs
  22. Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias
  23. Comparison between AlaTOP and IP8 inhalant panels on the Immulite 2000 analyzer
  24. External quality assessment of urinary methylmalonic acid quantification – results of a pilot study
Downloaded on 17.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.123/pdf
Scroll to top button